Ozempic price in Canada is coming down: what to expect and when

For millions of Canadians, the price of Ozempic has been the single biggest barrier to access. At $300 to $450 or more per month, it has remained out of reach for many people who could benefit from it. That changed on May 26, 2026, when Novo Nordisk announced it would cut the price of brand-name Ozempic for eligible Canadians to align with generic alternatives — the same week generics started arriving on pharmacy shelves.

What Novo Nordisk announced

On May 26, 2026, Novo Nordisk Canada announced that starting May 30, eligible Canadians who do not have public or private drug coverage will be able to purchase Ozempic at a reduced price that aligns with generic alternatives. The reduction is accessed through a Novo Nordisk Savings Card, available at local pharmacies across Canada (excluding Quebec) and applied automatically at Novo Nordisk Care Rx.

"We are dedicated to ensuring that eligible patients who choose Ozempic can stay on the brand because of these additional savings," said Iain Graham, general manager at Novo Nordisk Canada.

The announcement came the same week that Apotex, a Canadian-based generic manufacturer, began shipping its authorized generic semaglutide — and just weeks after Dr. Reddy's Laboratories received the first generic authorization on April 28, 2026.

Who qualifies for the Novo Nordisk price reduction

The savings card applies to eligible Canadians who do not have public or private drug coverage. Patients who are already covered under a provincial drug plan or private insurer are not the target of this program — the reduction is specifically designed for cash-pay patients who have been paying full price out of pocket.

The savings card is available at pharmacies across Canada, excluding Quebec. It is applied automatically at Novo Nordisk Care Rx.

If you currently have coverage that pays for some or all of Ozempic, speak with your pharmacist or benefits administrator to understand whether the savings card changes anything for your situation.

Why Novo Nordisk is doing this now

The timing is not coincidental. Generics from Dr. Reddy's and Apotex began arriving in pharmacies the same week as the announcement. With authorized generics priced at roughly one-third of Ozempic's list price, Novo Nordisk faced direct competition for cash-pay patients for the first time.

The brand-name drug price cut via savings card is Novo Nordisk's way of remaining competitive for patients who prefer to stay on the familiar product.

The broader access picture

This affordability shift matters beyond the numbers. GLP-1 drugs like Ozempic are generally covered for specific indications under public drug plans, but coverage for weight management has been limited. That coverage gap has left many Canadians paying out of pocket.

The combination of generics arriving at one-third the price and Novo Nordisk aligning its savings card price with generics represents the most significant affordability shift in the Canadian semaglutide market since Ozempic launched. For patients who have been priced out, or who stopped treatment due to cost, it is worth reassessing options with a licensed healthcare provider.

What to do now

If you have no drug coverage: Ask your pharmacist about the Novo Nordisk Savings Card 

If you have private insurance: Check whether your plan has listed generic semaglutide yet and whether it has a mandatory substitution policy. Some plans default to generics once listed. Contact your benefits administrator for current coverage status.

If you are currently on Ozempic and stable: There is no clinical urgency to switch. Speak with your licensed healthcare provider before changing your prescription, particularly if you are mid-titration or have responded well to your current treatment.

FAQs

Will the Novo Nordisk savings card price match the generic price?

Novo Nordisk stated the reduction is intended to align Ozempic's cost with generic alternatives for eligible cash-pay patients. Apotex has confirmed its generic is priced at approximately one-third of brand-name Ozempic. The savings card is designed to bring brand-name costs to a comparable level for qualifying patients.

Who qualifies for the reduced Ozempic price?

Eligible Canadians without public or private drug coverage. The savings card is available at pharmacies across Canada excluding Quebec, and applied automatically at Novo Nordisk Care Rx.

Are generics available at Canadian pharmacies now?

Yes. Apotex began shipping on May 27, 2026. Dr. Reddy's confirmed its product has arrived at select pharmacies and will be available more widely in the coming days. Ask your pharmacist for current stocking status at your location.

How much do the generics cost?

Apotex confirmed approximately one-third of the brand-name Ozempic price. At current Ozempic prices, that is roughly $100 to $150 per month depending on dose and pharmacy. Dr. Reddy's pricing has not been officially disclosed.